rs1317078806

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS1

The NM_006030.4(CACNA2D2):​c.17G>C​(p.Arg6Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000204 in 146,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R6W) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CACNA2D2
NM_006030.4 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.797

Publications

0 publications found
Variant links:
Genes affected
CACNA2D2 (HGNC:1400): (calcium voltage-gated channel auxiliary subunit alpha2delta 2) Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
CACNA2D2 Gene-Disease associations (from GenCC):
  • cerebellar atrophy with seizures and variable developmental delay
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09705219).
BP6
Variant 3-50503407-C-G is Benign according to our data. Variant chr3-50503407-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 461303.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000204 (30/146866) while in subpopulation EAS AF = 0.000809 (4/4942). AF 95% confidence interval is 0.000431. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA2D2NM_006030.4 linkc.17G>C p.Arg6Pro missense_variant Exon 1 of 38 ENST00000424201.7 NP_006021.2 Q9NY47-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA2D2ENST00000424201.7 linkc.17G>C p.Arg6Pro missense_variant Exon 1 of 38 1 NM_006030.4 ENSP00000390329.2 Q9NY47-2
CACNA2D2ENST00000423994.6 linkc.17G>C p.Arg6Pro missense_variant Exon 1 of 39 5 ENSP00000407393.2 C9JVC9
CACNA2D2ENST00000266039.7 linkc.17G>C p.Arg6Pro missense_variant Exon 1 of 38 1 ENSP00000266039.3 Q9NY47-3
CACNA2D2ENST00000360963.7 linkc.-2+662G>C intron_variant Intron 1 of 37 1 ENSP00000354228.3 Q9NY47-4

Frequencies

GnomAD3 genomes
AF:
0.000204
AC:
30
AN:
146776
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000622
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000676
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000806
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
71468
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
38268
African (AFR)
AF:
0.00
AC:
0
AN:
1620
American (AMR)
AF:
0.00
AC:
0
AN:
2264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2090
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1516
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7640
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
346
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
47392
Other (OTH)
AF:
0.00
AC:
0
AN:
4396
GnomAD4 genome
AF:
0.000204
AC:
30
AN:
146866
Hom.:
0
Cov.:
32
AF XY:
0.000196
AC XY:
14
AN XY:
71518
show subpopulations
African (AFR)
AF:
0.000621
AC:
25
AN:
40290
American (AMR)
AF:
0.0000675
AC:
1
AN:
14820
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3408
East Asian (EAS)
AF:
0.000809
AC:
4
AN:
4942
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4742
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9022
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
66386
Other (OTH)
AF:
0.00
AC:
0
AN:
2056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000174

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy Uncertain:1
Dec 21, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 6 of the CACNA2D2 protein (p.Arg6Pro). This variant is present in population databases (no rsID available, gnomAD 0.2%). This variant has not been reported in the literature in individuals affected with CACNA2D2-related conditions. ClinVar contains an entry for this variant (Variation ID: 461303). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cerebellar atrophy with seizures and variable developmental delay Benign:1
Sep 20, 2024
3billion
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
22
DANN
Benign
0.90
DEOGEN2
Benign
0.0073
.;T;.;.;T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.74
T;T;T;T;T
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.097
T;T;T;T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
1.1
.;.;L;L;L
PhyloP100
-0.80
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.45
N;N;N;N;N
REVEL
Benign
0.040
Sift
Benign
0.056
T;T;T;T;D
Sift4G
Benign
0.25
T;T;T;T;T
Polyphen
0.0
.;.;.;B;B
Vest4
0.21
MutPred
0.30
Loss of MoRF binding (P = 0);Loss of MoRF binding (P = 0);Loss of MoRF binding (P = 0);Loss of MoRF binding (P = 0);Loss of MoRF binding (P = 0);
MVP
0.068
MPC
0.24
ClinPred
0.097
T
GERP RS
-3.4
PromoterAI
0.060
Neutral
Varity_R
0.19
gMVP
0.41
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1317078806; hg19: chr3-50540838; API